1. Incidence of Statin Hepatotoxicity in Patients With Hepatitis C
Shirin Khorashadi, Noelle K. Hasson, Ramsey C. Cheung 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 7, Pages (July 2006)
DOI: /j.cgh
Copyright © 2006 American Gastroenterological Association Terms and Conditions

2. Figure 1
Percent change in liver enzyme levels from baseline to within 12 months after initiation of a statin therapy or diagnosis of hepatitis C in the no statin group. *P < .05 compared with the HCV-positive statin group. , HCV positive and no statin (n = 332); ■, HCV positive with statin (n = 166); □, HCV negative with statin (n = 332).
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

3. Figure 2
Frequency and degree of hepatotoxicity within 12 months after initiation of a statin therapy or diagnosis of hepatitis C in the no statin group. Severity of increases in liver biochemistry values as defined in text. *P < .05 compared with the HCV-positive statin group. , HCV positive and no statin (n = 332); ■, HCV positive with statin (n = 166); □, HCV negative with statin (n = 332).
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions